Orchid Pharma Limited (NSE:ORCHPHARMA)
India · Delayed Price · Currency is INR 991.00
-9.25 (-0.92%)
Jul 31, 2026, 3:30 PM IST
Orchid Pharma Market Cap
Orchid Pharma has a market cap or net worth of 50.04 billion as of July 31, 2026. Its market cap has increased by 39.91% in one year.
Market Cap
50.04B
Enterprise Value
52.83B
Revenue
8.11B
Ranking
n/a
PE Ratio
243.59
Stock Price
991.00
ChartMarket Cap Chart
Since November 3, 2020, Orchid Pharma's market cap has increased from 727.35M to 50.04B, an increase of 6,779.36%. That is a compound annual growth rate of 108.93%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 50.04B | 29.99% |
| Dec 31, 2025 | 38.49B | -58.00% |
| Dec 31, 2024 | 91.65B | 153.62% |
| Dec 29, 2023 | 36.14B | 143.20% |
| Dec 30, 2022 | 14.86B | -7.81% |
| Dec 31, 2021 | 16.12B | 223.64% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 3, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Akums Drugs and Pharmaceuticals | 101.74B |
| Strides Pharma Science | 97.70B |
| Sudeep Pharma | 96.71B |
| Sun Pharma Advanced Research Company | 67.64B |
| Aarti Pharmalabs | 61.13B |
| Innova Captab | 55.48B |
| RPG Life Sciences | 45.95B |
| Solara Active Pharma Sciences | 24.47B |